Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

177 results about "Acid molecule" patented technology

An acid is a molecule or ion capable of donating a hydron (proton or hydrogen ion H + ), or, alternatively, capable of forming a covalent bond with an electron pair (a Lewis acid ). The first category of acids is the proton donors or Brønsted acids.

Preparation method and application of covalent organic framework bipolar membrane

The invention belongs to the technical field of membrane separation, and aims to provide a preparation method and application of a covalent organic framework bipolar membrane. The method comprises the following steps: combining at least one amine, hydrazide or aldehyde monomer containing ionic groups with a monomer without ionic groups, and respectively synthesizing covalent organic framework COF nanosheets with positive charges and negative charges through a one-pot method under the condition of coexistence of an acid catalyst and an organic solvent; sequentially depositing COF nanosheets with positive and negative charges on the surface of the porous carrier by a hot solvent evaporation method; by constructing two COF separation layers with regular pore channels and opposite electrical properties, the covalent organic framework bipolar membrane with charge asymmetry is finally obtained. The product provided by the invention has high selectivity, can realize efficient separation of protons and metal cations, and significantly improves the extraction and recovery purity of hydrochloric acid; through charge repulsion and pore size screening mechanisms, separation of different anions can be further realized, and selective recovery of acid molecules is enhanced.
Owner:ZHEJIANG UNIV

Lipid compounds for delivery of therapeutic agents and preparation method and its use thereof

The present invention discloses lipid compounds for delivery of therapeutic agents and preparation method and its use thereof, specifically, the present invention discloses a compound of Formula I or a pharmaceutically acceptable salt, stereoisomer, tautomer, solvate, chelate, non-covalent complex, or precursor thereof, the ionizable lipid compounds of the present invention can effectively deliver nucleic acid molecules, small molecule compounds and other drugs, and by comparison, the lipid nanoparticles of the present invention have better particle size distribution, high encapsulation efficiency, and the delivery effect can be significantly better than the comparison lipid nanoparticles, which can meet the demand for in vivo delivery.
Owner:YOLTECH THERAPEUTICS CO LTD

Salicylic acid-cyclodextrin-amino acid ternary inclusion compound as well as preparation method and application thereof

The invention discloses a salicylic acid-cyclodextrin-amino acid ternary inclusion compound and a preparation method thereof. The salicylic acid-cyclodextrin-amino acid ternary inclusion compound is formed by salicylic acid, amino acid and a cyclodextrin derivative through non-covalent bond interaction, the cyclodextrin derivative is a cross-linked beta-cyclodextrin polymer, salicylic acid molecules are included in a cavity of the cross-linked beta-cyclodextrin polymer, and the cross-linked beta-cyclodextrin polymer is a cross-linked beta-cyclodextrin polymer. And meanwhile, guanidyl or carboxyl of an amino acid side chain interacts with hydroxyl outside the cross-linked beta-cyclodextrin polymer or an exposed part of an included salicylic acid molecule. According to the invention, a cross-linked beta-cyclodextrin polymer is used, arginine is introduced as a synergist, a salicylic acid-cross-linked beta-cyclodextrin polymer-arginine ternary clathrate compound is constructed, and through charge neutralization and hydrogen bond network synergistic effect, clathration efficiency is significantly improved, and water solubility of salicylic acid is improved.
Owner:AIXIMEI (ZHUHAI) BIOTECHNOLOGY CO LTD

Polynucleic acid molecules for inhibiting expression of LP(a) or APOC3, pharmaceutical compositions, and uses thereof

PCT designated stageWO2025170868A1Organic active ingredientsMetabolism disorderA lipoproteinApolipoprotein C3
Disclosed herein are polynucleic acid molecules that can be utilized for suppressing the expression of lipoprotein(a) (Lp(a)) gene or apolipoprotein C3 (APOC3). Also, described herein are pharmaceutical compositions comprising polynucleic acid molecules targeting lipoprotein(a) (Lp(a)) gene or apolipoprotein C3 (APOC3) mRNA. Further provided herein are methods for suppressing the expression of lipoprotein(a) (Lp(a)) gene or apolipoprotein C3 (APOC3) by utilizing the polynucleic acid molecules described herein.
Owner:SIRIUS THERAPEUTICS INC

Formation of sub-lithographic mandrel patterns using reversible overcoat

A method includes forming a plurality of first mandrels over a substrate, forming an overcoat layer over the plurality of first mandrels, and inducing a crosslinking reaction within the overcoat layer and form a crosslinked overcoat layer. The method further includes exposing the substrate to a radiation to generate a plurality of acid molecules within the plurality of first mandrels, diffusing a portion of the plurality of acid molecules from the plurality of first mandrels into portions of the crosslinked overcoat layer, and inducing a decrosslinking reaction within the portions of the crosslinked overcoat layer and form de-crosslinked regions. Unmodified regions of the crosslinked overcoat layer form a plurality of second mandrels. The method further includes selectively removing the de-crosslinked regions. The plurality of first mandrels and the plurality of second mandrels form a mandrel pattern over the substrate.
Owner:TOKYO ELECTRON LTD

Method for detecting and quantifying RNA

An aptamer nucleic acid molecule, a complex containing the aptamer and a small fluorophore molecule, a method for detecting intracellular or extracellular RNA, DNA or other target molecules using the aptamer nucleic acid molecule, and a kit containing the aptamer. The aptamer of the present disclosure can specifically bind with a small fluorophore molecule, and can significantly improve the fluorescence intensity thereof under the excitation of light of suitable wavelength.
Owner:FLUORESCENT DIAGNOSIS (SHANGHAI) BIOTECH CO LTD

Supramolecular amino-oligosaccharide, nano preparation containing supramolecular amino-oligosaccharide and preparation method and application of nano preparation

The invention relates to the technical field of pesticide preparation processing, in particular to supramolecular amino-oligosaccharide, a nano preparation containing the supramolecular amino-oligosaccharide and a preparation method and application of the supramolecular amino-oligosaccharide. The supramolecular amino-oligosaccharide is provided, and the supramolecular amino-oligosaccharide is obtained by combining amino-oligosaccharide with water molecules or hydrogen peroxide molecules through acid; wherein amino groups in the amino-oligosaccharide and carboxyl groups of acid can be subjected to an acid-base reaction to form chemical bonds such as amido bonds, meanwhile, water molecules or hydrogen peroxide molecules participate in the reaction process, hydrogen atoms in the water molecules or the hydrogen peroxide molecules and atoms such as nitrogen and oxygen in the amino-oligosaccharide or acid molecules can form hydrogen bonds, and the structure of the molecules can be stabilized; therefore, the overall charge state of the formed supramolecular amino-oligosaccharide is more stable, it is ensured that the amino-oligosaccharide is stable and not prone to being decomposed in the compounding process, the pesticide effect of the supramolecular amino-oligosaccharide can be effectively exerted, and application is promoted.
Owner:SHENZHEN NOPOSION AGROCHEM CO LTD

Lipid compound for delivering therapeutic agent as well as preparation method and application of lipid compound

The invention discloses a lipid compound for delivering a therapeutic agent as well as a preparation method and application of the lipid compound, and particularly discloses a compound shown in a formula I or pharmaceutically acceptable salt, stereoisomer, tautomer, solvate, chelate, non-covalent complex or precursor of the compound, the ionizable lipid compound can effectively deliver nucleic acid molecules, small molecule compounds and other drugs, and through comparison, the lipid nanoparticles are good in particle size distribution and high in encapsulation efficiency, the delivery effect can be obviously better than that of contrast lipid nanoparticles, and the requirement of in-vivo delivery can be met. (I)
Owner:YOLTECH THERAPEUTICS CO LTD

Methods of treating sarcoidosis with TNF alpha antibodies and related compositions and methods

Compositions and related methods are provided, the compositions comprising an anti-TNF alpha antibody sialylated with one or more N-acetylneuraminic acid molecules. In some embodiments, methods for treating or preventing sarcoidosis and / or granulomegaly or formation in a patient in need thereof are provided.
Owner:XENTRIA INC

Systems, compositions, and methods for uniquely identifying and analyzing nucleic acid molecules

Provided herein are systems, compositions, and methods for uniquely identifying and analyzing nucleic acid molecules. In particular, provided herein are systems, compositions, and methods employing modified base identifiers to generate a unique pattern in individual nucleic acid molecules and analyzing the modified molecules, or copies thereof, to identify or differentiate the molecules.
Owner:FLUID DISCOVERY

A simultaneous detection of As 3+ , Pb 2+ and Hg 2+ Nanocapsule-nucleic acid molecule complex and preparation method thereof

Environmental and water pollution caused by highly toxic heavy metals has always been a serious problem facing mankind. 3+ , Pb 2+ and Hg 2+ As are highly toxic and widely distributed environmental pollutants that pose a serious threat to the environment and humans even at low concentrations. The World Health Organization has set strict limits on drinking water standards. Therefore, it is necessary to establish an efficient and sensitive method for simultaneously detecting As 3+ , Pb 2+ and Hg 2+ The analysis method is crucial for environmental monitoring, food safety and other fields. The present invention proposes a nanocapsule-nucleic acid molecule complex based on nuclease cyclic amplification technology and molecular recognition technology and a preparation method thereof. The use of the complex can not only achieve As 3+ , Pb 2+ and Hg 2+ Simultaneous detection is achieved, and the detection sensitivity is significantly improved while ensuring high specificity. At the same time, a wider linear detection range is obtained.
Owner:QINGDAO UNIV OF SCI & TECH

A molecular chirality detection and identification method based on composite plasmon chiral nanostructures

The present invention provides a method for detecting and identifying molecular chirality based on a composite plasmon chiral nanostructure. The present invention constructs a composite plasmon chiral nanostructure using chiral nanofibers and gold nanorods as basic components, and achieves molecular chirality recognition and detection through plasmon chiral optical amplification. The excellent plasmon circular dichroism optical properties of the composite nanostructure can convert the host-guest chiral recognition interaction occurring at the fiber interface into an asymmetric plasmon chiral optical amplification signal. This technology can detect and identify the chiral enantiomers of amino acid molecules in about 1 minute, with a sensitivity of 10 ‑6 mol / L. This structure can also be used for quantitative analysis of molecular enantiomeric excess (ee), with a detection sensitivity of ±0.05. Furthermore, given that the chiral host-guest complexes involved in this technology are primarily based on hydrogen bonding interactions, the chiral fiber host can be used as a universal substrate for the detection of chiral amino acid molecules.
Owner:BEIJING INST OF TECH

Modified short interfering nucleic acid (siNA) molecules and uses thereof

Short interfering nucleic acid (siNA) molecules, compositions, and methods containing modified nucleotides and their uses are described.
Owner:ALIGOS THERAPEUTICS INC

Synthesis of 5-nucleotide dithiophosphamide and application of 5-nucleotide dithiophosphamide in oligonucleotide

The invention discloses synthesis of 5-nucleotide phosphorodithioamide and application of the 5-nucleotide phosphorodithioamide in oligonucleotide. The oligonucleotide modified by the phosphorodithioamide comprises nucleotide structural units shown in a formula I or a formula II,..., the formula I,..., the formula II. According to the invention, through specific limitation of the structure of a nucleotide dithiophosphoramide monomer, the prepared oligonucleotide comprises a 5-nucleotide dithiophosphoramide structural unit. Compared with a traditional oligonucleotide molecule, the oligonucleotide molecule modified by nucleotide dithiophosphoramide shows better enzymatic degradation resistance and pharmaceutical stability. In addition, the binding performance between the modified oligonucleotide molecules and environmental ions can be improved through nucleotide dithiophosphamide modification, and a novel chemical modification strategy is provided for research, development and application of oligonucleotide drugs.
Owner:SUZHOU SHENGNUOWEI BIOTECH CO LTD

Una amidites and uses thereof

To provide novel linkers for better stabilizing and / or lower toxicity, optimization of binding moiety for increased target specificity and / or target delivery, and nucleic acid polymer modifications for increased stability and / or reduced off-target effect.SOLUTION: Disclosed herein are a composition and a pharmaceutical formulation that comprise a binding moiety conjugated to a modified polynucleic acid molecule and a polymer. Also described herein is a method for treating a disease which utilize a composition or a pharmaceutical formulation comprising a binding moiety conjugated to a polynucleic acid molecule and a polymer.SELECTED DRAWING: Figure 1B
Owner:AVIDITY BIOSCI INC

Tin alloy plating solution

PCT designated stageWO2026177032A1Active agentPhenyl group
This tin alloy plating solution comprises: (A) a soluble salt that contains at least a stannous salt; (B) a soluble salt of a metal that is nobler than tin; (C) a leveling agent that is composed of an alkanesulfonic acid which contains 9-18 carbon atoms in each molecule or a salt thereof; (D) a free acid; (E) a nonionic surfactant that contains one or more phenyl groups in each molecule; and (F) an EO / PO block polymer that has an EO group at an end. The EO ratio in the EO / PO block polymer is within the range of 20 mol% to 50 mol% inclusive, and the molecular weight of the EO / PO block polymer is within the range of 1,500 to 3,500 inclusive.
Owner:MITSUBISHI MATERIALS CORP

Acid-base dual closed-loop recovery system and recovery method for the resource utilization of weak organic acid salt wastewater

This invention discloses a closed-loop acid-base recovery system and method for the resource recovery of weak organic acid salt wastewater. The front-end neutralization unit neutralizes fresh organic acid wastewater with alkali solution to generate a weak organic acid salt solution to be treated, which is then fed into a diffusion dialysis unit. The diffusion dialysis unit is divided into a diffusion liquid channel and a receiving liquid channel by a diffusion dialysis anion exchange membrane, achieving pre-enrichment of organic acid ions through concentration difference. The bipolar membrane electrodialysis unit, driven by a DC electric field, breaks down the weak organic acid salt into organic acid and alkali solution. The inlet of the acid chamber is connected to the diffusion liquid outlet of the diffusion dialysis unit, and all the produced dilute organic acid solution is transported to the diffusion dialysis unit as an acid receiving liquid for recycling. All the regenerated alkali solution produced in the alkali chamber is transported to the front-end neutralization unit for recycling. The receiving liquid outlet of the diffusion dialysis unit is connected to an acid product collection unit. This invention fundamentally inhibits the back diffusion of weak acid molecules, achieving efficient recovery of organic acids and recycling of alkali solution.
Owner:SHANGHAI HONESS ENVIRONMENTAL TECH CORP

A double-stranded nucleic acid conjugate, and methods of making and using the same

The present invention relates to a nucleic acid conjugate and methods of making and using the same, comprising: a first nucleic acid molecule, a second nucleic acid molecule, and a linker, the first nucleic acid molecule being linked to the second nucleic acid molecule by the linker, the linker linking the first nucleic acid molecule and the second nucleic acid molecule by a phosphodiester (p) or phosphorothioate (s) linkage, the linker being selected from the structures shown in Formula (I):
Owner:SHENZHEN SALUBRIS PHARMA CO LTD

Terminal thiophosphorylation modified threose nucleic acid and application thereof in oligonucleotide

The invention relates to the technical field of biological medicine, and particularly discloses synthesis and application of oligonucleotide with threose nucleic acid 3-oxygen at the tail end indirectly connected with thiophosphoric acid. The chemical modification strategy comprises the following steps: O < 3->-oxygen of threose nucleic acid is connected with thiophosphoric acid through a spacer group, and O < 2->-hydroxyl is combined with a nucleotide monomer of phosphoramidite; carrying out solid-phase synthesis on the threose nucleic acid O2 '-phosphoramidite monomer to construct an oligonucleotide molecule; the oxygen of the threose nucleic acid at the terminal of the oligonucleotide is linked to the thiophosphoric acid through a spacer group, and since the type of phosphonic acid does not belong to a substrate of phosphatase, the modified oligonucleotide can resist exonuclease degradation and improve its in vivo biological activity.
Owner:SUZHOU SHENGNUOWEI BIOTECH CO LTD

SiRNA conjugate as well as preparation method and application thereof

The present invention relates to a siRNA conjugate and a preparation method and use thereof, the siRNA conjugate comprises: a first nucleic acid molecule, a second nucleic acid molecule and a linker, the first nucleic acid molecule is connected to the second nucleic acid molecule through the linker, the linker is respectively connected to the first nucleic acid molecule and the second nucleic acid molecule through phosphate (p) or thiophosphate (s), the linker is selected from at least one of A1, A2, A3, A4, A5, A6 or A7, or any combination thereof.
Owner:SHENZHEN SALUBRIS PHARMA CO LTD

Controllable preparation method of alpha-Fe2O3 nanostructure

The embodiment of the invention discloses a controllable preparation method of an alpha-Fe2O3 nanostructure, which comprises the following steps: S1, stirring and mixing amino acid and a NaOH aqueous solution to obtain a first mixed solution; s2, mixing and stirring a FeCl3. 6H2O aqueous solution and the first mixed solution to obtain a second mixed solution; s3, mixing and stirring a urea aqueous solution, a polyethylene glycol-1500 aqueous solution and the second mixed solution to obtain a third mixed solution; and S4, carrying out a hydrothermal reaction on the third mixed solution, and separating a reaction product to obtain the alpha-Fe2O3 nanostructure formed by regulating nanowire assembly through amino acid molecules. According to the method, amino acid molecules are used for regulating and controlling the growth process of the nanowires, the alpha-Fe2O3 nanostructure is assembled, morphology regulation and control of the alpha-Fe2O3 nanostructure can be achieved through the concentration of the amino acid, and the nanostructures in different shapes such as cubes, nanowires and oval particles are obtained.
Owner:ZHENGZHOU UNIV

Preparation method of chiral dendronized diacetylene acid molecule and supramolecular chiral assembly of chiral dendronized diacetylene acid molecule

The invention discloses a preparation method of a chiral dendronized diacetylene acid molecule and a supramolecular chiral assembly of the chiral dendronized diacetylene acid molecule, and relates to the field of intelligent chiral materials.The preparation method comprises the steps that firstly, tree-shaped alkoxy ether is combined with PCDA through lysine, the tree-shaped alkoxy ether serves as a hydrophilic element, lysine serves as a chiral source and can provide a large number of hydrogen bonds, the PCDA serves as a hydrophobic element, and the supermolecular chiral assembly of the chiral dendronized diacetylene acid molecule is obtained; chiral dendronized diacetylene acid molecules are designed and synthesized; then, supermolecule chiral assembly is carried out through driving of non-covalent interaction, and supermolecule chiral assembly is regulated and controlled through temperature and light; furthermore, the supramolecular chiral assembly is subjected to optical topological polymerization reaction to prepare the valence-donating chiral polymer. The invention opens up a new way for creating a novel intelligent chiral nano material with a special structure and excellent characteristics.
Owner:SHANGHAI UNIV

COMPOSITION AND METHODS RELATED TO MODIFICATION OF 5 HYDROXYMETHYLCYTOSINE (5-hmC)

The present invention relates generally to the field of molecular biology. More particularly, it concerns methods and compositions for detecting, evaluating, and / or mapping 5-hydroxymethyl-modified cytosine bases within a nucleic acid molecule.
Owner:UNIVERSITY OF CHICAGO

Modeling method, device, computer-readable storage medium, and processor

The application provides a modeling method, device, computer readable storage medium and processor. The method comprises the following steps: determining an initial number of acid molecules according to the concentration of a photoacid generator and a Poisson generator, determining an initial number of base molecules according to the concentration of a base quencher and a Poisson generator, and determining an initial number of protected groups in a polymer resin according to the concentration of the polymer resin and a Poisson generator; in the determining step, determining the number of protected groups at the next moment according to the number of protected groups at the current moment, determining the number of acid molecules at the next moment according to the number of acid molecules at the current moment, and determining the number of base molecules at the next moment according to the number of base molecules at the current moment; the determining step is repeated for multiple times until the next moment of the current time is the ending moment of the photoresist baking. The method solves the technical problem that the randomness of molecules is ignored in the prior art when performing nanoscale photoetching modeling.
Owner:GUANGDONG GREATER BAY AREA INST OF INTEGRATED CIRCUIT & SYST

A reversible single-molecule switch based on local cation regulation

ActiveCN115955899BElectrochemical scanning tunneling microscopeChemical physics
The application discloses a reversible single-molecule switch based on local cation regulation and belongs to the technical field of molecular electronics. The application is based on the crack junction technology of an electrochemical scanning tunneling microscope. The distribution of local cations in an interface double electric layer is changed by controlling an electric potential, so that the state of a carboxylic acid molecule is influenced. The contact action of the carboxylic acid molecule and a gold needle tip is adjusted, and a single-molecule switch is realized. The electric potential is-0.5-0V. The application proves the influence of local cations in an electrochemical interface on carboxyl molecules, and opens up a new way for realizing the practical application of a reversible single-molecule switch through a gate electrode.
Owner:ZHEJIANG NORMAL UNIV

Method for constructing library based on large-fragment nucleic acid molecules

The invention relates to a method for constructing a library based on large-fragment nucleic acid molecules. The invention also relates to a kit used in the method, and a library obtained by using the method.
Owner:BEIJING QUANPU MEDICAL LAB CO LTD